Drug-resistant TB risk demands push for new drugs
LONDON – Multi-drug resistant strains of tuberculosis (TB) could become dominant forms of the disease in the next few decades,
LONDON – Multi-drug resistant strains of tuberculosis (TB) could become dominant forms of the disease in the next few decades,
New York and Bangalore, India, May 3, 2010 – The Global Alliance for TB Drug Development (TB Alliance) and AstraZeneca
Six REMoxTB clinical trial sites in Kenya, South Africa, Tanzania and Zambia commemorated World TB Day through the TB Alliance’s
Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership (PDP) accelerating the discovery and development of
The Global Health Technologies Coalition (GHTC) launched its first annual report on global health research and development. The report focuses
On April 21, 2010, the Global Health Technologies Coalition (GHTC) will host its first annual Congressional expo to highlight the
FORT COLLINS – Colorado State University tuberculosis researcher Anne Lenaerts will represent tuberculosis research on World TB Day, March 24,
The following commentary was submitted, by the CEOs of the TB Alliance and Aeras Global TB Vaccine Foundation, to the
The Stop TB Partnership’s Working Group on New TB Drugs (WGND) has launched an interactive platform that will mobilize robust
The Global Alliance for TB Drug Development (TB Alliance) today announced the appointment of Dr. Carlos Morel to its Board